Fast-Acting Touch Surface Antimicrobial
- Funded by Roche Holding AG (Roche)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Funder
Roche Holding AG (Roche)Principal Investigator
Matt HodgsonResearch Location
CanadaLead Research Institution
Outbreaker Solutions North AmericaResearch Priority Alignment
N/A
Research Category
Infection prevention and control
Research Subcategory
Barriers, PPE, environmental, animal and vector control measures
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This project focuses on the testing and commercialization of a patented and fast-acting antimicrobial surface made from compressed sodium chloride (CSC) for high hand traffic fixtures such as door handles and railings. The product provides a fast-acting antimicrobial effect without any behaviour change required for training or operation. Sodium chloride, the active ingredient in CSC, is the only antimicrobial surface that eliminates bacteria, fungi and viruses in under 5 minutes. Other surfaces take at least 2 hours, during which the surface is not safe to touch. A research partnership has been established for rapid SARS-CoV-2 testing on our CSC surface and additional virus strains.